Q/C Technologies, Inc. (QCLS) stock
QCLSNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$0.28−0.02 (-5.95%)
Close on Nov 20, 2026Market cap $2.28MP/E –Yield –
Q/C Technologies net income
Net income is the profit left for shareholders after every expense, interest and tax.
Q/C Technologies's net income for the twelve months ending Jun 30, 2026 was -$16.57M. For fiscal 2025 it was -$11.63M. The highest annual figure on record is -$1.53M in fiscal 2013.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$11.63M | – |
| FY2024 | Dec 31, 2024 | -$23.36M | – |
| FY2023 | Dec 31, 2023 | -$4.00M | – |
| FY2022 | Dec 31, 2022 | -$15.20M | – |
| FY2021 | Dec 31, 2021 | -$29.89M | – |
| FY2020 | Dec 31, 2020 | -$9.49M | – |
| FY2019 | Dec 31, 2019 | -$3.89M | – |
| FY2018 | Dec 31, 2018 | -$10.85M | – |
| FY2017 | Dec 31, 2017 | -$7.37M | – |
| FY2016 | Dec 31, 2016 | -$3.30M | – |
| FY2015 | Dec 31, 2015 | -$9.31M | – |
| FY2014 | Dec 31, 2014 | -$3.14M | – |
| FY2013 | Dec 31, 2013 | -$1.53M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$6.62M | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.24M | – |
| Q4 FY2025 | Dec 31, 2025 | -$5.89M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.81M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.80M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.12M | -127.8% |
| Q4 FY2024 | Dec 31, 2024 | -$2.06M | – |
| Q1 FY2024 | Mar 31, 2024 | -$9.80M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.36M | – |
| Q3 FY2023 | Sep 30, 2023 | $4.04M | – |
| Q2 FY2023 | Jun 30, 2023 | -$4.17M | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.51M | – |
| Q4 FY2022 | Dec 31, 2022 | -$3.75M | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.69M | – |
| Q2 FY2022 | Jun 30, 2022 | -$3.64M | – |
| Q1 FY2022 | Mar 31, 2022 | -$4.12M | – |
| Q4 FY2021 | Dec 31, 2021 | -$3.24M | – |
| Q3 FY2021 | Sep 30, 2021 | -$5.47M | – |
| Q2 FY2021 | Jun 30, 2021 | -$18.09M | – |
| Q1 FY2021 | Mar 31, 2021 | -$3.09M | – |
| Q4 FY2020 | Dec 31, 2020 | -$4.17M | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.24M | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.09M | – |
| Q1 FY2020 | Mar 31, 2020 | -$981.95K | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.34M | – |
| Q3 FY2019 | Sep 30, 2019 | -$837.03K | – |
| Q2 FY2019 | Jun 30, 2019 | -$794.89K | – |
| Q1 FY2019 | Mar 31, 2019 | -$916.96K | – |
| Q4 FY2018 | Dec 31, 2018 | -$3.84M | – |
| Q3 FY2018 | Sep 30, 2018 | -$3.08M | – |
| Q2 FY2018 | Jun 30, 2018 | -$2.07M | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.86M | -699.7% |
| Q2 FY2017 | Jun 30, 2017 | -$818.01K | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.35M | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.10M | – |
| Q3 FY2016 | Sep 30, 2016 | $310.16K | – |
| Q2 FY2016 | Jun 30, 2016 | -$1.01M | – |
| Q1 FY2016 | Mar 31, 2016 | -$1.51M | – |
See a number that looks wrong?